SCHEMBL7556527

SCHEMBL7556527

N#Cc1ccc(NC(=O)Nc2cccc3c2OCO3)c(O)c1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CXCR2 P25025 4/20 0.58
▸ CXCR1 P25024 3/20 0.58
▸ ALDH1A1 P00352 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ ACVRL1 P37023 1/20 0.42
▸ XDH P47989 1/20 0.42
▸ SLC22A12 Q96S37 1/20 0.42
▸ MEN1 O00255 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ CCR3 P51677 3/20 0.40
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ PKM P14618 1/20 0.38
▸ KDM4C Q9H3R0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3706598 0.78 MEN1 (0.59) CXCR2CXCR1POLBMAPK1LMNA
SCHEMBL5595003 0.75 CXCR2 (0.66) CXCR2CXCR1ALDH1A1MAPK1KDM4E
SCHEMBL7514963 0.75 CXCR2 (0.73) CXCR2CXCR1ALDH1A1POLBMAPK1
SCHEMBL3705632 0.74 CXCR2 (1.00) CXCR2CXCR1ALDH1A1LMNAMEN1
SCHEMBL6824309 0.74 CXCR2 (1.00) CXCR2CXCR1ALDH1A1LMNAMEN1
SCHEMBL3710548 0.74 CXCR2 (0.71) CXCR2CXCR1ALDH1A1POLBMAPK1
SCHEMBL7489930 0.73 CXCR2 (1.00) CXCR2CXCR1ALDH1A1POLBMAPK1
SCHEMBL3709514 0.72 CXCR2 (0.71) CXCR2CXCR1ALDH1A1KDM4EHPGD
SCHEMBL5594865 0.72 CXCR2 (0.71) CXCR2CXCR1ALDH1A1KDM4EHPGD
SCHEMBL3707120 0.71 CXCR1 (0.67) CXCR2CXCR1ALDH1A1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020128321-A1 IL-8 receptor antagonists SMITHKLINE BEECHAM CORPORATION 2002-09-12 — — US disclosed
US-6262113-B1 HYDROXY- OR MERCAPTO-PHENYLUREAS SMITHKLINE BEECHAM CORPORATION 2001-07-17 — — US disclosed
US-6211373-B1 Phenyl urea antagonists of the IL-8 receptor SMITHKLINE BEECHAM CORPORATION 2001-04-03 — — US disclosed
US-5780483-A IL-8 receptor antagonists SMITHKLINE BEECHAM CORPORATION (US) 1998-07-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128321-A1 IL-8 receptor antagonists CXCL8, CCR8, IL1RN CXCR2 15/4885CXCR1 21/4885ALDH1A1 2239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback